Osteogenesis imperfecta with normal sclerae, dominant form: genes and variants
Explore variant evidence for Osteogenesis imperfecta with normal sclerae, dominant form across 2 analyzed proteins (COL1A2, COL1A1). Linked ClinVar records include 85 pathogenic or likely pathogenic variants, 7 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Osteogenesis imperfecta with normal sclerae, dominant form
COL1A2: Collagen alpha-2(I) chain
It contributes one of the three chains of type I collagen, providing tensile strength to bone, skin, tendon, blood vessels, and other connective tissues. Pathogenic variants can cause osteogenesis imperfecta, Ehlers-Danlos phenotypes, and related connective-tissue disorders.
51 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in COL1A2 have source records linked to Osteogenesis imperfecta with normal sclerae, dominant form. Association strength is not clinical gene validity.
COL1A1: Collagen alpha-1(I) chain
The alpha-1 chain of type I collagen, the main fibrillar collagen in connective tissue, bone, and skin. Together with its partner chain, it forms strong extracellular fibers, and COL1A1 variants are associated with osteogenesis imperfecta and several Ehlers-Danlos syndromes.
34 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in COL1A1 have source records linked to Osteogenesis imperfecta with normal sclerae, dominant form. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Osteogenesis imperfecta with normal sclerae, dominant form
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| COL1A2 G646V | 646 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G316S | 316 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G322S | 322 | Pathogenic / likely pathogenic (★★) | |
| COL1A1 G380S | 380 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1022A | 1022 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1079S | 1079 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A2 G292D | 292 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G292C | 292 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 C1195R | 1195 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A1 G365V | 365 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 D1219G | 1219 | Pathogenic / likely pathogenic (★★) | |
| COL1A1 R1014C | 1014 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1181S | 1181 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A2 G184D | 184 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G193C | 193 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G253D | 253 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G262R | 262 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G274V | 274 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G328S | 328 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G331S | 331 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G349S | 349 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G379E | 379 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G391R | 391 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G427S | 427 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G469A | 469 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G481R | 481 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G487R | 487 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G499S | 499 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G661R | 661 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G664V | 664 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G700R | 700 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G733C | 733 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G772R | 772 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G835D | 835 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G874A | 874 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G901C | 901 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G937C | 937 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G973D | 973 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G982S | 982 | Pathogenic / likely pathogenic (★★) | |
| COL1A2 G997S | 997 | Pathogenic / likely pathogenic (★★) | |
| COL1A1 G203D | 203 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G260D | 260 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G329R | 329 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G332R | 332 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G362S | 362 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G368A | 368 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G425S | 425 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G488S | 488 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G626S | 626 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G821S | 821 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1001S | 1001 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1046C | 1046 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1052A | 1052 | Triple-helical region | Pathogenic / likely pathogenic (★★) |
| COL1A1 T1298N | 1298 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A1 W1325C | 1325 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A1 A1387T | 1387 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A1 D1441H | 1441 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A1 A1443V | 1443 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A1 G1448R | 1448 | Fibrillar collagen NC1 | Pathogenic / likely pathogenic (★★) |
| COL1A2 A1119T | 1119 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 85.
Which prediction tools work for Osteogenesis imperfecta with normal sclerae, dominant form
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 94 out of 100
- PolyPhen-2: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 91 out of 100
- MetaLR: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 88 out of 100
- phyloP: 84 out of 100
- Pangolin: 74 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 59 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Osteogenesis imperfecta also has ClinVar records linked to COL1A2 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (332 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome, classic also has ClinVar records linked to COL1A2 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (265 pathogenic / likely pathogenic).
- Osteogenesis imperfecta, perinatal lethal also has ClinVar records linked to COL1A2 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (42 pathogenic / likely pathogenic).
- Combined osteogenesis imperfecta and Ehlers-Danlos syndrome also has ClinVar records linked to COL1A2 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (11 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome, arthrochalasia also has ClinVar records linked to COL1A2 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (7 pathogenic / likely pathogenic).
- Osteogenesis imperfecta also has ClinVar records linked to COL1A1 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (239 pathogenic / likely pathogenic).
- Osteogenesis imperfecta, perinatal lethal also has ClinVar records linked to COL1A1 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (52 pathogenic / likely pathogenic).
- Caffey disease also has ClinVar records linked to COL1A1 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (15 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome, arthrochalasia also has ClinVar records linked to COL1A1 variants; they fall mostly in different places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (10 pathogenic / likely pathogenic).
- Combined osteogenesis imperfecta and Ehlers-Danlos syndrome also has ClinVar records linked to COL1A1 variants; they fall partly in the same places as the Osteogenesis imperfecta with normal sclerae, dominant form variants (6 pathogenic / likely pathogenic).
Diseases related to Osteogenesis imperfecta with normal sclerae, dominant form
- Osteogenesis imperfecta, also linked to COL1A1 and COL1A2
- Ehlers-Danlos syndrome, classic, also linked to COL1A1 and COL1A2
- Ehlers-Danlos syndrome, also linked to COL1A1 and COL1A2
- Osteogenesis imperfecta, perinatal lethal, also linked to COL1A1 and COL1A2
- Connective tissue disease, also linked to COL1A1 and COL1A2
- Ehlers-Danlos syndrome, arthrochalasia, also linked to COL1A1 and COL1A2
- Combined osteogenesis imperfecta and Ehlers-Danlos syndrome, also linked to COL1A1 and COL1A2
- Osteoporosis, also linked to COL1A1 and COL1A2
- Postmenopausal osteoporosis, also linked to COL1A1 and COL1A2
- Phenylketonuria, also linked to COL1A1
- Caffey disease, also linked to COL1A1
- Fetal anomalies with a likely genetic cause, also linked to COL1A1
Frequently asked questions
Which genes have records linked to Osteogenesis imperfecta with normal sclerae, dominant form?
This view contains 2 analyzed proteins: COL1A2, COL1A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 85 pathogenic or likely pathogenic variants, 7 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 101 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center